Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.41 - $1.94 $72,474 - $99,716
-51,400 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$1.61 - $2.77 $348,887 - $600,259
-216,700 Reduced 80.83%
51,400 $93,000
Q4 2020

Feb 16, 2021

SELL
$1.55 - $2.24 $111,755 - $161,504
-72,100 Reduced 21.19%
268,100 $469,000
Q3 2020

Nov 16, 2020

BUY
$1.91 - $3.08 $620,368 - $1 Million
324,800 Added 2109.09%
340,200 $663,000
Q2 2020

Aug 14, 2020

BUY
$1.97 - $3.98 $30,338 - $61,292
15,400 New
15,400 $43,000
Q1 2020

May 15, 2020

SELL
$1.17 - $3.0 $17,784 - $45,600
-15,200 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$1.16 - $1.42 $7,191 - $8,804
-6,200 Reduced 28.97%
15,200 $19,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.65 $8,712 - $11,880
-7,200 Reduced 25.17%
21,400 $28,000
Q2 2019

Aug 14, 2019

BUY
$1.39 - $2.03 $3,197 - $4,669
2,300 Added 8.75%
28,600 $48,000
Q1 2019

May 15, 2019

BUY
$1.39 - $1.71 $36,557 - $44,973
26,300 New
26,300 $39,000
Q4 2018

Feb 14, 2019

SELL
$1.41 - $2.16 $52,734 - $80,784
-37,400 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$1.86 - $2.18 $21,204 - $24,852
-11,400 Reduced 23.36%
37,400 $79,000
Q2 2018

Aug 14, 2018

BUY
$1.76 - $2.79 $85,888 - $136,152
48,800 New
48,800 $96,000
Q1 2018

May 15, 2018

SELL
$1.34 - $2.03 $30,016 - $45,471
-22,400 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$1.65 - $2.45 $23,100 - $34,300
-14,000 Reduced 38.46%
22,400 $41,000
Q3 2017

Nov 14, 2017

BUY
$1.5 - $2.55 $54,600 - $92,820
36,400
36,400 $75,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.